The impact of chemoimmunotherapy on primary cold agglutinin disease and Waldenstr&#246;m macroglobulinemia-associated cold agglutinin syndrome.

Rituxan (rituximab) - Roche

http://www.ncbi.nlm.nih.gov/pubmed/42755913

Kazuhiko Hirano; Kenichi Ito; Naohiro Sekiguchi; Saya Motohashi; Tomoko Kitagawa

Sep 19, 2026